Table III.
Adverse Event | Patients, No. (%) | |
---|---|---|
Darusentan (n=76) | Placebo (n=39) | |
Peripheral edema | 13 (17) | 2 (5) |
Headache | 8 (11) | 2 (5) |
Sinusitis | 6 (8) | 0 |
Dizziness | 5 (7) | 1 (3) |
Nasopharyngitis | 5 (7) | 1 (3) |
Upper respiratory tract infectionb | 4 (5) | 2 (5) |
Gastroenteritis | 4 (5) | 1 (3) |
Arthralgia/arthritis | 2 (3) | 6 (15) |
Diarrhea | 1 (1) | 2 (5) |
aOccurred in ≥5% of patients in a treatment group. bIncluded patients with symptoms of an upper respiratory tract infection. |